TY  - JOUR

T1  - Safety and efficacy of autologous haematopoietic stem-cell
transplantation with low-dose cyclophosphamide
mobilisation and reduced intensity conditioning versus
standard of care in refractory Crohn’s disease (ASTIClite):
an open-label, multicentre, randomised controlled trial

JO  - The Lancet Gastroenterology and Hepatology

PY  - 2024/02/07

AU  - Swaby E

ED  - 

PB  - Elsevier

Y2  - 2024/12/22

ER  -